Pharmafile Logo
Pharmafocus logo
Advanced Search

Dr Samson Fung

January 4, 2023
Business Services

Molecure Appoints Dr. Samson Fung, Chief Medical Officer to its Management Board as it Continues to Focus on Successfully Progressing …

Appointment

Actimed Therapeutics successfully closes second tranche of £10m seed financing to progress pipeline for treatment of cancer cachexia and other muscle wasting disorders

January 4, 2023
Business Services

London, UK – 4 January 2023. Actimed Therapeutics Ltd, a UK based clinical stage specialty pharmaceutical company focused on bringing …

News
Press release

FDA expands access to abortion pills

January 4, 2023
Medical Communications

Following new rules from the FDA under the Biden administration, patients can now obtain the abortion pill mifepristone from retail …

News

Novartis pays $245m to settle Exforge generic pay-for-delay lawsuit

January 4, 2023
Medical Communications

Swiss pharma company Novartis will settle a classic generic pay-for-delay legal battle with direct purchasers, indirect purchasers and retailers regarding …

News

FDA grants Breakthrough Device Designation for Burning Rock’s multi-cancer detecting test

January 4, 2023
Medical Communications

Burning Rock, a Chinese biotech company which focuses on the applications of next-generation sequencing (NGS) technology in the field of …

News

FDA expected to make decision on controversial Alzheimer’s drug this week

January 4, 2023
Medical Communications

The FDA are expected to come to a decision on Eisai and Biogen’s Alzheimer’s drug lecanemab by the end of …

News

Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia

January 3, 2023
Business Services

Milan, Italy, Jan. 3, 2023, 07:00 am CET – Newron Pharmaceuticals S.p.A.

News
Press release

Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Talquetamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

January 3, 2023
Business Services

BEERSE, BELGIUM, 3 January 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a …

News
Press release

Cost of over 350 drugs expected to increase in 2023

January 3, 2023
Sales and Marketing

With many pharma companies preparing for President Joe Biden’s Inflation Reduction Act (IRA) to begin having an impact, and inflation …

News

Rare cancer drug for young patients approved

January 3, 2023
Research and Development

A new treatment option for adult and paediatric patients with a rare soft tissue cancer has been approved. The FDA …

News

MediWound receives FDA approval for NexoBrid

January 3, 2023
Medical Communications

Israeli biopharma company MediWound has secured FDA approval for its wound care product NexoBrid (anacaulase-bcdb). US-based biopharma company Vericel will …

News

Datar blood test receives FDA Breakthrough Designation

January 3, 2023
Medical Communications

Datar Cancer Genetics has secured FDA Breakthrough Designation for their blood test used to detect inaccessible brain tumours, where traditional …

News

BioNTech begins phase 1 trial for malaria vaccine

December 23, 2022
Medical Communications

BioNTech has announced the start of its new first-in-human phase 1 trial for BNT165b1, a candidate from its programme which …

News

Celltrion submits application for CT-P13 SC to FDA

December 23, 2022
Medical Communications

Celltrion has announced that it has finalised its submission of a biologics license application for the subcutaneous version of a …

News

Moderna signs ten-year deal with UK Government for vaccine production

December 23, 2022
Manufacturing and Production

US biotech company Moderna has finalised a partnership with the UK government to produce vaccines, the main element of which …

News

COVID-19 antiviral treatment shown to speed up recovery in trial

December 23, 2022
Medical Communications

Molnupiravir, made by Merck, Sharp and Dohme (MSD), has been found to reduce the recovery time of COVID-19 patients, however …

News

Treatment for rare, paediatric growth hormone deficiency recommended by NICE for use on the NHS

December 22, 2022
Medical Communications

Walton Oaks, 22 December 2022 – Pfizer Ltd today announces that the National Institute for Health and Care Excellence (NICE) …

News
Press release

AstraZeneca shares two new drug approvals in the EU

December 22, 2022
Medical Communications

On Wednesday, AstraZeneca announced two drug approvals in the European Union (EU). The first being Imfinzi’s approval for the treatment …

News

Everest Medicines and licensing partner Pfizer receive FDA and EMA approval for ulcerative colitis drug

December 22, 2022
Medical Communications

Everest Medicines, a biopharmaceutical company, has announced that its licensing partner, Pfizer, has received acceptance from the FDA for a …

News

New monoclonal antibody for hospitalised COVID-19 patients approved by FDA

December 22, 2022
Medical Communications

The FDA has approved Roche’s monoclonal antibody which treats hospitalised adult patients with COVID-19. The antibody, Actemra, is already approved …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026